Upregulation of IGF-1R Expression during Neoadjuvant Therapy Predicts Poor Outcome in Breast Cancer Patients

• Sandra Heskamp ,

  * E-mail: sandra.heskamp@radboudumc.nl

  Affiliations Department of Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands, Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands

  ⨯
• Otto C. Boerman,

  Affiliation Department of Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

  ⨯
• Janneke D. M. Molkenboer-Kuenen,

  Affiliation Department of Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

  ⨯
• Carla A. Wauters,

  Affiliation Department of Pathology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands

  ⨯
• Luc J. A. Strobbe,

  Affiliation Department of Surgery, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands

  ⨯
• Caroline M. P. W. Mandigers,

  Affiliation Department of Internal Medicine, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands

  ⨯
• Peter Bult,

  Affiliation Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

  ⨯
• Wim J. G. Oyen,

  Affiliation Department of Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

  ⨯
• Winette T. A. van der Graaf,

  Affiliation Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands

  ⨯
• Hanneke W. M. van Laarhoven

  Affiliations Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands, Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

  ⨯